BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23866897)

  • 1. Topical bexarotene for psoralen plus ultraviolet A-induced photodamage.
    Deonizio JM; Vaghani SP; Guitart J
    J Am Acad Dermatol; 2013 Aug; 69(2):e96-8. PubMed ID: 23866897
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A.
    Coors EA; Von den Driesch P
    Br J Dermatol; 2005 Jun; 152(6):1379-81. PubMed ID: 15949024
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
    Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
    Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides.
    Huang J; Cowper S; Moss J; Girardi M
    J Drugs Dermatol; 2013 Apr; 12(4):487-9. PubMed ID: 23652902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bexarotene plus PUVA plus radiation combination therapy for mycosis fungoides.
    Coors E
    Dermatol Clin; 2008 Jan; 26 Suppl 1():33-5. PubMed ID: 18405185
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of a folliculotropic mycosis fungoides with bexarotene and PUVA.
    Krönke A; Schlaak M; Arin M; Mauch C; Kurschat P
    Eur J Dermatol; 2012; 22(2):259-60. PubMed ID: 22240623
    [No Abstract]   [Full Text] [Related]  

  • 7. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M; García-Arpa M; González-García J
    Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bexarotene salvage therapy in a patient with refractory erythrodermic mycosis fungoides after failure on interferon/PUVA and methotrexate.
    Dalle S; Thomas L
    Dermatol Clin; 2008 Jan; 26 Suppl 1():39-41. PubMed ID: 18405186
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of mycosis fungoides with oral bexarotene combined with PUVA.
    Stern DK; Lebwohl M
    J Drugs Dermatol; 2002 Sep; 1(2):134-6. PubMed ID: 12847736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of mycosis fungoides with psoralen and long-wave ultraviolet light-A (PUVA).
    Nozicková M; Simková M; Nozicka Z
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1987; 30(1):179-94. PubMed ID: 3481871
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of new lesions: a complication of psoralen plus ultraviolet A light therapy for mycosis fungoides.
    Fernandes S; Marques Pinto G; Cardoso J
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):278-9. PubMed ID: 22971198
    [No Abstract]   [Full Text] [Related]  

  • 12. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
    D'Acunto C; Gurioli C; Neri I
    J Dermatolog Treat; 2010 Jan; 21(1):45-8. PubMed ID: 19603308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Granulomatous mycosis fungoides: combination therapy with bexarotene and PUVA].
    Wirtz M; Helbig D
    Hautarzt; 2014 Apr; 65(4):274-6. PubMed ID: 24671704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ poikilodermatous mycosis fungoides with a nonaggressive clinical behaviour and a good response to psoralen plus ultraviolet A treatment.
    Ada S; Güleç AT
    Br J Dermatol; 2007 Nov; 157(5):1064-6. PubMed ID: 17854364
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of refractory stage IV mycosis fungoides with bexarotene monotherapy.
    Otremba B
    Dermatol Clin; 2008 Jan; 26 Suppl 1():51-2. PubMed ID: 18405188
    [No Abstract]   [Full Text] [Related]  

  • 16. Bexarotene monotherapy for patients with refractory early stage mycosis fungoides.
    Stein A
    Dermatol Clin; 2008 Jan; 26 Suppl 1():67-70. PubMed ID: 18405191
    [No Abstract]   [Full Text] [Related]  

  • 17. Bexarotene monotherapy for patients with advanced stage mycosis fungoides.
    Bachelez H
    Dermatol Clin; 2008 Jan; 26 Suppl 1():25-6. PubMed ID: 18405183
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of light-sensitive mycosis fungoides with PUVA and prednisolone.
    Molin L; Volden G
    Photodermatol; 1987 Apr; 4(2):106-7. PubMed ID: 3658820
    [No Abstract]   [Full Text] [Related]  

  • 19. Ichthyosiform mycosis fungoides.
    Badawy E; D'Incan M; El Majjaoui S; Franck F; Fabricio L; Dereure O; Souteyrand P; Guillot B
    Eur J Dermatol; 2002; 12(6):594-6. PubMed ID: 12459538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoides.
    Michaelis S; Cozzio A; Kempf W; Graf P; Burg G; Dummer R
    Dermatology; 2004; 209(1):72-4. PubMed ID: 15237276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.